Key Dates
None.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for Cystic Fibrosis (CF) Research and Translation Centers. CF Research and Translation Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program. These CF Centers provide shared resources to support research to develop and test new therapies for CF and to foster collaborations among institutions with a strong existing research base in CF. The NIDDK currently supports seven CF Research and Translation Centers located at institutions with documented programs of research excellence in basic and clinical CF Research. Information about the currently funded CF Research and Translation Centers may be found at:
https://www.niddk.nih.gov/research-funding/research-programs/cystic-fibrosis-research-translation-centers or https://www.cysticfibrosiscenters.org/.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The NOFO is expected to be published in April 2024 with an expected application due date in July 2024.
This NOFO will utilize the P30 activity code. Details of the planned NOFO are provided below.
This Notice encourages investigators with expertise and insights of clinical and basic aspects of Cystic Fibrosis to begin to consider applying for this new NOFO.
In addition, collaborative investigations combining expertise in clinical and basic aspects of Cystic Fibrosis will be encouraged and these investigators should also begin considering applying for this application.
Among the areas of research encouraged in this initiative are clinical and basic aspects of Cystic Fibrosis research examining the mechanisms that underlie the basis of Cystic Fibrosis, as well as research designed to improve the translation of existing knowledge of strategies for the prevention and treatment of Cystic Fibrosis.
Funding Information
6.2 million dollars
5
$750,000 direct costs per year. Equipment costs (only allowed for the first year) and indirect costs on subcontracts are not included in the $750,000 direct cost cap. Equipment requests are capped at $100,000 and may be limited by available funds.
93.847
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Regional Organization
Eligible Agencies of the Federal Government
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Thomas L Eggerman, MD, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8813
Email: eggermant@mail.nih.gov
and Human Services (HHS)
